Cargando…
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily using mesenchymal stem (stromal) cells (MSCs), have demonstrated safety and possible efficacy in patients with acute respiratory dis...
Autores principales: | Khoury, Maroun, Cuenca, Jimena, Cruz, Fernanda F., Figueroa, Fernando E., Rocco, Patricia R.M., Weiss, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144273/ https://www.ncbi.nlm.nih.gov/pubmed/32265310 http://dx.doi.org/10.1183/13993003.00858-2020 |
Ejemplares similares
-
Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2017) -
Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2015) -
Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2015) -
Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome
por: Alcayaga-Miranda, Francisca, et al.
Publicado: (2023) -
Delivery of affordable and scalable encapsulated allogenic/autologous mesenchymal stem cells in coagulated platelet poor plasma for dental pulp regeneration
por: Angelopoulos, Ioannis, et al.
Publicado: (2022)